Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Basal Cell 4Pilonidal Sinus 2Chalazion 2Bone Neoplasms 2Recurrence 1Pain 1Keratosis, Actinic 1Giant Cell Tumors 1Giant Cell Tumor of Bone 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Chondrosarcoma 1Chondroma 1Carcinoma, Squamous Cell 1Bone Cysts 1

Interventions

Paclitaxel 95Carboplatin 76pembrolizumab 72Cisplatin 28Bevacizumab 27Surveys and Questionnaires 23Radiotherapy 22Letrozole 22Doxorubicin 21Megestrol Acetate 20olaparib 19lenvatinib 19Taxes 17Specimen Handling 17Docetaxel 17Nivolumab 16Magnetic Resonance Spectroscopy 16dostarlimab 15Metformin 15Observation 13Gemcitabine 13Blood Specimen Collection 13Biopsy 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11temsirolimus 10abemaciclib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Curettage × Clear all
NCT01961102 2016-08-09

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Krankenhaus Barmherzige Schwestern Linz

Completed
300 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡